1,4-phenylenebis(methylene)selenocyanate has been researched along with Colonic Neoplasms in 7 studies
1,4-phenylenebis(methylene)selenocyanate: structure given in first source; inhibits DMBA-induced carcinogenesis by inhibiting DMBA-DNA adduct formation
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of p-XSC against colon cancer is significantly augmented by a low-fat diet." | 1.31 | Mechanisms in the chemoprevention of colon cancer: modulation of protein kinase C, tyrosine protein kinase and diacylglycerol kinase activities by 1,4-phenylenebis-(methylene)selenocyanate and impact of low-fat diet. ( El-Bayoumy, K; Hirose, Y; Rao, CV; Reddy, BS; Simi, B; Upadhyaya, P, 2000) |
| "We have consistently shown that several synthetic Organoselenium compounds are superior cancer chemopreventive agents and less toxic than selenite or certain naturally occurring selenoamino acids." | 1.31 | Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. ( Cooma, I; El-Bayoumy, K; Rao, CV; Reddy, BS; Rodriguez, JG; Simi, B; Wang, CQ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartram, HP | 1 |
| Krüger, S | 1 |
| Dusel, G | 1 |
| El-Bayoumy, K | 6 |
| Upadhyaya, P | 4 |
| Scheppach, W | 1 |
| Narayanan, BA | 1 |
| Narayanan, NK | 1 |
| Desai, D | 1 |
| Pittman, B | 2 |
| Reddy, BS | 6 |
| Rivenson, A | 2 |
| Rao, CV | 4 |
| Samaha, HS | 1 |
| Hamid, R | 1 |
| Simi, B | 2 |
| Hirose, Y | 1 |
| Wang, CQ | 1 |
| Rodriguez, JG | 1 |
| Cooma, I | 1 |
| Kulkarni, N | 1 |
7 other studies available for 1,4-phenylenebis(methylene)selenocyanate and Colonic Neoplasms
| Article | Year |
|---|---|
Antiproliferative effect of 1,4-phenylenebis(methylene)selenocyanate (p-XSC) on colonic epithelium of patients with adenomatous polyps in vitro.
Topics: Adenomatous Polyps; Anticarcinogenic Agents; Biomarkers; Biopsy; Cell Culture Techniques; Cell Divis | 2003 |
Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Blotting, Western; Caco-2 Cells; Cell Survival; Colo | 2004 |
Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Anticarcinogenic Agents; Azoxymethane; Colonic Neopla | 1997 |
The role of apoptosis in the modulation of colon carcinogenesis by dietary fat and by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Carcinogens; Colonic Neoplasms; Dietary F | 1997 |
Mechanisms in the chemoprevention of colon cancer: modulation of protein kinase C, tyrosine protein kinase and diacylglycerol kinase activities by 1,4-phenylenebis-(methylene)selenocyanate and impact of low-fat diet.
Topics: Animals; Anticarcinogenic Agents; Colonic Neoplasms; Diacylglycerol Kinase; Dietary Fats; Dinoprost; | 2000 |
Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogens; Colonic Neoplasms; Cyclooxygenase 1; Cy | 2001 |
Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Body Weight; Colonic Neopla | 1992 |